{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:30:52Z","timestamp":1782901852954,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:00:00Z","timestamp":1430611200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s13277-015-3450-y","type":"journal-article","created":{"date-parts":[[2015,5,2]],"date-time":"2015-05-02T10:16:08Z","timestamp":1430561768000},"page":"7725-7733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro"],"prefix":"10.1007","volume":"36","author":[{"given":"Xiaohan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenglin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoao","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshuang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,3]]},"reference":[{"key":"3450_CR1","volume":"5","author":"F Kokka","year":"2014","unstructured":"Kokka F, Bryant A, Brockbank E, Jeyarajah A. Surgical treatment of stage IA2 cervical cancer. Cochrane Database Syst Rev. 2014;5, CD010870. doi: 10.1002\/14651858.CD010870.pub2 .","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3450_CR2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/088282403322017866","volume":"16","author":"GL Eiben","year":"2003","unstructured":"Eiben GL, da Silva DM, Fausch SC, Le Poole IC, Nishimura MI, Kast WM. Cervical cancer vaccines: recent advances in HPV research. Viral Immunol. 2003;16(2):111\u201321. doi: 10.1089\/088282403322017866 .","journal-title":"Viral Immunol"},{"key":"3450_CR3","author":"JM Brotherton","year":"2014","unstructured":"Brotherton JM. Human papillomavirus vaccination: where are we now? J Paediatr Child Health. 2014. doi: 10.1111\/jpc.12627 .","journal-title":"J Paediatr Child Health"},{"key":"3450_CR4","author":"L He","year":"2014","unstructured":"He L, Wu L, Su G, Wei W, Liang L, Han L, et al. The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer. Gynecol Oncol. 2014. doi: 10.1016\/j.ygyno.2014.06.001 .","journal-title":"Gynecol Oncol"},{"issue":"75","key":"3450_CR5","first-page":"125","volume":"14","author":"L Denny","year":"2012","unstructured":"Denny L. Cervical cancer: prevention and treatment. Discov Med. 2012;14(75):125\u201331.","journal-title":"Discov Med"},{"issue":"2","key":"3450_CR6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/1568009611313020009","volume":"13","author":"GP Yee","year":"2013","unstructured":"Yee GP, de Souza P, Khachigian LM. Current and potential treatments for cervical cancer. Curr Cancer Drug Targets. 2013;13(2):205\u201320.","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"3450_CR7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.cellsig.2013.02.013","volume":"25","author":"K Liu","year":"2013","unstructured":"Liu K, Lin B, Zhao M, Yang X, Chen M, Gao A, et al. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cell Signal. 2013;25(5):1264\u201371. doi: 10.1016\/j.cellsig.2013.02.013 .","journal-title":"Cell Signal"},{"key":"3450_CR8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2407-11-42","volume":"11","author":"C Lengerke","year":"2011","unstructured":"Lengerke C, Fehm T, Kurth R, Neubauer H, Scheble V, Muller F, et al. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma. BMC Cancer. 2011;11:42. doi: 10.1186\/1471-2407-11-42 .","journal-title":"BMC Cancer"},{"issue":"4","key":"3450_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061427","volume":"8","author":"V Velcheti","year":"2013","unstructured":"Velcheti V, Schalper K, Yao X, Cheng H, Kocoglu M, Dhodapkar K, et al. High SOX2 levels predict better outcome in non-small cell lung carcinomas. PLoS One. 2013;8(4), e61427. doi: 10.1371\/journal.pone.0061427 .","journal-title":"PLoS One"},{"issue":"12","key":"3450_CR10","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1245\/s10434-009-0617-z","volume":"16","author":"S Saigusa","year":"2009","unstructured":"Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy. Ann Surg Oncol. 2009;16(12):3488\u201398. doi: 10.1245\/s10434-009-0617-z .","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3450_CR11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2184.2012.00812.x","volume":"45","author":"F Lin","year":"2012","unstructured":"Lin F, Lin P, Zhao D, Chen Y, Xiao L, Qin W, et al. Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis. Cell Prolif. 2012;45(3):207\u201316. doi: 10.1111\/j.1365-2184.2012.00812.x .","journal-title":"Cell Prolif"},{"issue":"4","key":"3450_CR12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/carcin\/bgt410","volume":"35","author":"K Hutz","year":"2014","unstructured":"Hutz K, Mejias-Luque R, Farsakova K, Ogris M, Krebs S, Anton M, et al. The stem cell factor SOX2 regulates the tumorigenic potential in human gastric cancer cells. Carcinogenesis. 2014;35(4):942\u201350. doi: 10.1093\/carcin\/bgt410 .","journal-title":"Carcinogenesis"},{"issue":"1","key":"3450_CR13","first-page":"203","volume":"19","author":"Z Yang","year":"2014","unstructured":"Yang Z, Pan X, Gao A, Zhu W. Expression of Sox2 in cervical squamous cell carcinoma. J BUON. 2014;19(1):203\u20136.","journal-title":"J BUON"},{"issue":"10","key":"3450_CR14","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.humpath.2009.11.021","volume":"41","author":"J Ji","year":"2010","unstructured":"Ji J, Zheng PS. Expression of Sox2 in human cervical carcinogenesis. Hum Pathol. 2010;41(10):1438\u201347. doi: 10.1016\/j.humpath.2009.11.021 .","journal-title":"Hum Pathol"},{"issue":"2","key":"3450_CR15","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","volume":"105","author":"S Pecorelli","year":"2009","unstructured":"Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009;105(2):103\u20134.","journal-title":"Int J Gynaecol Obstet"},{"issue":"14","key":"3450_CR16","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gng073","volume":"31","author":"SN Peirson","year":"2003","unstructured":"Peirson SN, Butler JN, Foster RG. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 2003;31(14), e73.","journal-title":"Nucleic Acids Res"},{"issue":"38","key":"3450_CR17","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/onc.2008.224","volume":"27","author":"TT Maliekal","year":"2008","unstructured":"Maliekal TT, Bajaj J, Giri V, Subramanyam D, Krishna S. The role of Notch signaling in human cervical cancer: implications for solid tumors. Oncogene. 2008;27(38):5110\u20134. doi: 10.1038\/onc.2008.224 .","journal-title":"Oncogene"},{"issue":"5","key":"3450_CR18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1158\/1078-0432.CCR-11-2485","volume":"18","author":"JK Schwarz","year":"2012","unstructured":"Schwarz JK, Payton JE, Rashmi R, Xiang T, Jia Y, Huettner P, et al. Pathway-specific analysis of gene expression data identifies the PI3K\/Akt pathway as a novel therapeutic target in cervical cancer. Clin Cancer Res. 2012;18(5):1464\u201371. doi: 10.1158\/1078-0432.CCR-11-2485 .","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3450_CR19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/bjc.2011.94","volume":"104","author":"R Xiang","year":"2011","unstructured":"Xiang R, Liao D, Cheng T, Zhou H, Shi Q, Chuang TS, et al. Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer. Br J Cancer. 2011;104(9):1410\u20137. doi: 10.1038\/bjc.2011.94 .","journal-title":"Br J Cancer"},{"issue":"8","key":"3450_CR20","volume":"7","author":"X Han","year":"2012","unstructured":"Han X, Fang X, Lou X, Hua D, Ding W, Foltz G, et al. Silencing SOX2 induced mesenchymal-epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS ONE. 2012;7(8), e41335. doi: 10.1371\/journal.pone.0041335 .","journal-title":"PLoS ONE"},{"issue":"10","key":"3450_CR21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/omi.2013.0058","volume":"17","author":"X Lou","year":"2013","unstructured":"Lou X, Han X, Jin C, Tian W, Yu W, Ding D, et al. SOX2 targets fibronectin 1 to promote cell migration and invasion in ovarian cancer: new molecular leads for therapeutic intervention. OMICS. 2013;17(10):510\u20138. doi: 10.1089\/omi.2013.0058 .","journal-title":"OMICS"},{"issue":"7","key":"3450_CR22","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/cas.12155","volume":"104","author":"Y Gen","year":"2013","unstructured":"Gen Y, Yasui K, Nishikawa T, Yoshikawa T. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT\/mammalian target of rapamycin complex 1 signaling pathway. Cancer Sci. 2013;104(7):810\u20136. doi: 10.1111\/cas.12155 .","journal-title":"Cancer Sci"},{"issue":"36","key":"3450_CR23","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1038\/onc.2011.561","volume":"31","author":"W Qin","year":"2012","unstructured":"Qin W, Dong P, Ma C, Mitchelson K, Deng T, Zhang L, et al. MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene. 2012;31(36):4067\u201375. doi: 10.1038\/onc.2011.561 .","journal-title":"Oncogene"},{"issue":"1","key":"3450_CR24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1042\/BJ20061489","volume":"404","author":"SI Gharbi","year":"2007","unstructured":"Gharbi SI, Zvelebil MJ, Shuttleworth SJ, Hancox T, Saghir N, Timms JF, et al. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem J. 2007;404(1):15\u201321. doi: 10.1042\/BJ20061489 .","journal-title":"Biochem J"},{"issue":"3","key":"3450_CR25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1158\/1535-7163.MCT-08-0570","volume":"8","author":"F Marampon","year":"2009","unstructured":"Marampon F, Bossi G, Ciccarelli C, Di Rocco A, Sacchi A, Pestell RG, et al. MEK\/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma. Mol Cancer Ther. 2009;8(3):543\u201351. doi: 10.1158\/1535-7163.MCT-08-0570 .","journal-title":"Mol Cancer Ther"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3450-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-3450-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-3450-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:29:20Z","timestamp":1559489360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-3450-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,3]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["3450"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-3450-y","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,3]]}}}